Mianserin

Mianserin is a dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used to treat depression throughout Europe and elsewhere. Among its listed roles, it functions as a antidepressant, a histamine agonist, a sedative, an alpha-adrenergic antagonist, an adrenergic uptake inhibitor, a serotonergic antagonist, a H1-receptor antagonist, an EC 3.4.21.26 (prolyl oligopeptidase) inhibitor and a geroprotector. It is grouped under the following drug class(es): Psychotropic agents, Sedatives and Serotonin agents. Its therapeutic use is listed as antidepressants. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Tolvon, Mianseryna, (+-)-Athymil, 2-Methyl-1, 2, 3, 4, 10, 14b-hexahydrodibenzo[c, f]pyrazino[1 and 2-a]azepine. Its PubChem CID is 4184.

CAS No 24219-97-4
Molecular Formula C18H20N2
Molecular Weight 264.40 g/mol
Synonyms 5-methyl-2,5-diazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(19),8,10,12,15,17-hexaene

Frequently Asked Questions